fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% recall: Sterility Concern
fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, 250 mL bag, Rx only…
Why was fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% recalled?
Lack of assurance of sterility:
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot: 17-275929, Exp. 10/12/2023,
- Product
- fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, 250 mL bag, Rx only…
- Recalling firm
- Central Admixture Pharmacy Services Inc
- Quantity
- 60 250 mL bags
- Distribution
- Nationwide in the USA
- Recall date
- October 11, 2023
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)